img
img
img
img
img
img
img
img
img
img

Biotechnology and Biosimilars' cGMP Training

2017-10-19
Refresher training related to “Biotechnology and Biosimilars” cGMP based on FDA 21 CFR Parts 210, 211, 600 to 680 and other International guidelines was conducted for our Insulin and Eryhthropoietin Plant teams.
 
The training was highly interactive with lots of real-world examples related to the field.
 
This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, refer to our Cookie Policy.